Autopsy report · NCT04758858

Carbohydrates Under Target for Type 1 Diabetes Management

“Not approved by REB”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Na

Sponsor

Institut de Recherches Cliniques de Montreal

Sponsor type

University, hospital or other

Conditions

Type 1 Diabetes

Interventions

Insulin treatment optimization with participant's usual diet; Abbott's FreeStyle Libre; Three-day food journal; Medical visit; Blood pressure measurements; Anthropometric parameters measurements

Participants

0

Sites

1

Countries

Canada

Trials that died the same way

• The Laser in Pseudoexfoliation (LIP) Study
  “Did not submit to the REB” (79% match in meaning)
• Coronary Artery Study in Pediatric Heart Transplantation
  “never approved by IRB” (74% match in meaning)
• Antenatal Development Evaluated Prospectively
  “Not IRB approved” (71% match in meaning)
• Changes in Bleeding and Clotting During the Menstrual Cycle
  “IRB Approval lapsed” (64% match in meaning)
• Psychiatric Outcomes of Unruptured Intracranial Aneurysms (POUIA)
  “IRB approval has lapsed. Study has submitted continuing review report for re-certification. Awaiting IRB re-approval.” (60% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.